RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
The Latest on: Viral diseases
Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics: Proceedings of a Workshop
on July 19, 2018 at 12:16 am
The opioid epidemic is changing the epidemiology of HIV, hepatitis, and other infectious disease. To address the infectious disease consequences of the opioid crisis, a public workshop titled Integrat... […]
Infectious Disease Testing Markets to 2021: Emerging Opportunities in Americas, EMEA & APAC - Supplier Shares & Strategies, Test Volume & Sales Segment Forecasts, Technology ...
on July 18, 2018 at 11:23 am
DUBLIN--(BUSINESS WIRE)--The "2018 Infectious Disease Testing Market 2021: Emerging Opportunities in the Americas, EMEA, APAC - A 74-Country Analysis - Supplier Shares and Strategies, Test Volume and ... […]
State in Sh6.2 b strategy to combat viral sheep and goat disease
on July 18, 2018 at 9:48 am
Principal Secretary State Department of Livestock Harry Kimtai (Centre) and other officials during the launch of the National PPR (Peste Des Petits Ruminants) Control and Eradication Strategy in Nairo... […]
HIV infection doubles risk of heart disease
on July 18, 2018 at 9:03 am
Analysis of global figures reveals that HIV-associated cardiovascular disease has more than tripled in the past 20 years as more people are living longer with the virus. The greatest impact is in sub- ... […]
Explainer: How do mosquitoes transfer viruses, diseases
on July 17, 2018 at 5:05 pm
Texas is seeing its first human cases of West Nile Virus of the year, and the number of mosquitoes carrying the virus seems to be growing. New numbers show four people in the state have contracted the ... […]
Diagnostic Microbiology and Infectious Disease Publishes New Clinical Study Data on Karius Test
on July 17, 2018 at 3:39 pm
Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announce... […]
UGA scientists move forward in research to predict infectious disease outbreaks
on July 17, 2018 at 9:30 am
A group of ecologists at the University of Georgia might be a little closer to developing an early warning system for epidemics, according to a University of Georgia press release. A team led by Eamon ... […]
New Grant Offering Signals Increased Role for Infectious Diseases…
on July 17, 2018 at 3:35 am
New Grant Offering Signals Increased Role for Infectious Diseases Specialists Researching Alzheimer’s Causation, Says Dr. Leslie Norins of Alzheimer’s Germ Quest, Inc. Emeritus member of Infectious Di... […]
Deadly Infectious Disease Outbreaks Are Occurring All Over the World
on July 16, 2018 at 5:21 pm
Dr. Alex Berezow joined the American Council on Science and Health as Senior Fellow of Biomedical Science in May 2016. Dr. Berezow is a prolific science writer whose work has appeared in multiple outl... […]
European Infectious Disease Point-of-Care Testing (POCT) Market Growth Insights 2018 - Forecast to 2022 - ResearchAndMarkets.com
on July 16, 2018 at 8:51 am
DUBLIN--(BUSINESS WIRE)--The "Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022" report has been added to ResearchAndMarkets.com's offering. The res... […]
via Google News and Bing News